Found: 90
Select item for more details and to access through your institution.
True DisCoVeRy of COVID-19 Disease Burden Versus Speculated Antiviral Cardiovascular Risk Requires a Control Group.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Biomarkers in pulmonary infections: a clinical approach.
- Published in:
- Annals of Intensive Care, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13613-024-01323-0
- By:
- Publication type:
- Article
In adults with COVID-19 and severe hypoxemia, lower vs. higher oxygenation targets increased days alive without life support.
- Published in:
- Annals of Internal Medicine, 2024, v. 177, n. 7, p. JC77, doi. 10.7326/ANNALS-24-00558-JC
- By:
- Publication type:
- Article
Remdesivir is Associated with Reduced Mortality in Patients Hospitalized for COVID-19 Not Requiring Supplemental Oxygen.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 6, p. 1, doi. 10.1093/ofid/ofae202
- By:
- Publication type:
- Article
Improving Sepsis Outcomes in the Era of Pay-for-Performance and Electronic Quality Measures: A Joint IDSA/ACEP/PIDS/SHEA/SHM/SIDP Position Paper.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 3, p. 505, doi. 10.1093/cid/ciad447
- By:
- Publication type:
- Article
A Randomized, Open-Label, Non-inferiority Clinical Trial Assessing 7 Versus 14 Days of Antimicrobial Therapy for Severe Multidrug-Resistant Gram-Negative Bacterial Infections: The OPTIMISE Trial Protocol.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 1, p. 237, doi. 10.1007/s40121-023-00897-9
- By:
- Publication type:
- Article
Remdesivir Reduced Mortality in Immunocompromised Patients Hospitalized for COVID-19 Across Variant Waves: Findings From Routine Clinical Practice.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 12, p. 1626, doi. 10.1093/cid/ciad460
- By:
- Publication type:
- Article
Remdesivir Is Associated With Reduced Mortality in COVID-19 Patients Requiring Supplemental Oxygen Including Invasive Mechanical Ventilation Across SARS-CoV-2 Variants.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 10, p. 1, doi. 10.1093/ofid/ofad482
- By:
- Publication type:
- Article
Translating Clinical Trial Results to Clinical Practice During a Pandemic.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 4, p. 321, doi. 10.1001/jama.2023.11260
- By:
- Publication type:
- Article
REMDESIVIR REDUCES MORTALITY IN HOSPITALIZED COVID-19 PATIENTS ACROSS VARIANT ERAS.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 218
- By:
- Publication type:
- Article
REMDESIVIR REDUCES MORTALITY IN IMMUNOCOMPROMISED PATIENTS HOSPITALIZED FOR COVID-19.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 219
- By:
- Publication type:
- Article
REMDESIVIR IS ASSOCIATED WITH REDUCED READMISSION AFTER COVID-19 HOSPITALIZATION.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 219
- By:
- Publication type:
- Article
Less Is More: A 7-Day Course of Antibiotics Is the Evidence-Based Treatment for Pseudomonas aeruginosa Ventilator-Associated Pneumonia.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 4, p. 750, doi. 10.1093/cid/ciac809
- By:
- Publication type:
- Article
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians.
- Published in:
- Intensive Care Medicine, 2023, v. 49, n. 2, p. 142, doi. 10.1007/s00134-022-06956-y
- By:
- Publication type:
- Article
Adjunctive Rifampin Following Debridement and Implant Retention for Staphylococcal Prosthetic Joint Infection: Is it Effective if not Combined With a Fluoroquinolone?
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 12, p. 1, doi. 10.1093/ofid/ofac582
- By:
- Publication type:
- Article
The Potential for Increasing Risk of Consent Refusal in COVID-19 Trials: Considering Underlying Reasons and Responses.
- Published in:
- Annals of the American Thoracic Society, 2022, v. 19, n. 9, p. 1446, doi. 10.1513/AnnalsATS.202203-250VP
- By:
- Publication type:
- Article
Risk of COVID‐19 in Rheumatoid Arthritis: A National Veterans Affairs Matched Cohort Study in At‐Risk Individuals.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 12, p. 2179, doi. 10.1002/art.41800
- By:
- Publication type:
- Article
A Sepsis Screening Tool for Hematopoietic Cell Transplant Recipients Remains Elusive.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 7, p. 1230, doi. 10.1093/cid/ciaa221
- By:
- Publication type:
- Article
Infectious Diseases Society of America Position Paper: Recommended Revisions to the National Severe Sepsis and Septic Shock Early Management Bundle (SEP-1) Sepsis Quality Measure.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 4, p. 541, doi. 10.1093/cid/ciaa059
- By:
- Publication type:
- Article
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 3.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 2, p. e1, doi. 10.1002/art.41596
- By:
- Publication type:
- Article
Strength of Recommendation and Quality of Evidence for Recommendations in Current Infectious Diseases Society of America Guidelines.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 2, p. 1, doi. 10.1093/ofid/ofab033
- By:
- Publication type:
- Article
Less is more: critically ill status is not a carte blanche for unlimited antibiotic use.
- Published in:
- Intensive Care Medicine, 2020, v. 46, n. 11, p. 2075, doi. 10.1007/s00134-020-06260-7
- By:
- Publication type:
- Article
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 2.
- Published in:
- Arthritis & Rheumatology, 2020, v. 72, n. 9, p. e1, doi. 10.1002/art.41437
- By:
- Publication type:
- Article
Sepsis in Immunocompromised Patients Without Human Immunodeficiency Virus.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Need for Additional Trials of Vitamin C for Sepsis-Reply.
- Published in:
- 2020
- By:
- Publication type:
- letter
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 1.
- Published in:
- Arthritis & Rheumatology, 2020, v. 72, n. 8, p. 1241, doi. 10.1002/art.41301
- By:
- Publication type:
- Article
Remdesivir for the Treatment of Covid-19 -- Preliminary Report.
- Published in:
- Ophthalmology Update, 2020, v. 18, n. 3, p. 50
- By:
- Publication type:
- Article
Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Advanced Preparation Makes Research in Emergencies and Isolation Care Possible: The Case of Novel Coronavirus Disease (COVID-19).
- Published in:
- American Journal of Tropical Medicine & Hygiene, 2020, v. 102, n. 5, p. 926, doi. 10.4269/ajtmh.20-0205
- By:
- Publication type:
- Article
Lack of Benefit of High-Dose Vitamin C, Thiamine, and Hydrocortisone Combination for Patients With Sepsis.
- Published in:
- 2020
- By:
- Publication type:
- editorial
2204. Microbiology of Pneumonia Due to Co-Infection in the ICU: Impact of Host Immune Status.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S751, doi. 10.1093/ofid/ofz360.1884
- By:
- Publication type:
- Article
2216. Pneumonia in the ICU: Epidemiology and Outcomes.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S756, doi. 10.1093/ofid/ofz360.1894
- By:
- Publication type:
- Article
2240. Can Antibiotic Duration Be Reduced by the Sequential Use of Procalcitonin and Endotoxin in Patients with Sepsis? A Prospective Double-Blind Clinical Trial.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S766, doi. 10.1093/ofid/ofz360.1918
- By:
- Publication type:
- Article
Changes in lung microbiome do not explain the development of ventilator-associated pneumonia.
- Published in:
- 2019
- By:
- Publication type:
- editorial
Influenza virus-related critical illness: pathophysiology and epidemiology.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Reply to Al-Hasan and Justo.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Didn't inhale? Time to reconsider aerosolized antibiotics in the treatment of ventilator-associated pneumonia.
- Published in:
- 2018
- By:
- Publication type:
- editorial
Clinical failure with and without empiric atypical bacteria coverage in hospitalized adults with community-acquired pneumonia: a systematic review and meta-analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Telavancin in the Recent Hospital Acquired and Ventilator Associated Pneumonia (HAP/VAP) 2016 Guidelines.
- Published in:
- 2017
- By:
- Publication type:
- Letter to the Editor
Clinical presentation and outcomes of norovirus infection in intestinal allograft compared to native intestine.
- Published in:
- Transplant Infectious Disease, 2017, v. 19, n. 3, p. n/a, doi. 10.1111/tid.12692
- By:
- Publication type:
- Article
Reply to Daniels et al.
- Published in:
- 2017
- By:
- Publication type:
- Letter to the Editor
Viral and bacterial co-infection in pneumonia: do we know enough to improve clinical care?
- Published in:
- 2017
- By:
- Publication type:
- editorial
Predictors of persistent diarrhea in norovirus enteritis after solid organ transplantation.
- Published in:
- Clinical Transplantation, 2016, v. 30, n. 11, p. 1488, doi. 10.1111/ctr.12844
- By:
- Publication type:
- Article
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, n. 5, p. 575, doi. 10.1093/cid/ciw504
- By:
- Publication type:
- Article
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, n. 5, p. e61, doi. 10.1093/cid/ciw353
- By:
- Publication type:
- Article
Secondary Infection in Patients With Sepsis.
- Published in:
- 2016
- By:
- Publication type:
- commentary
Reply to Thomason et al and Bahr et al.
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
A Randomized 2x2 Factorial Clinical Trial of Renal Transplantation: Steroid-Free Maintenance Immunosuppression with Calcineurin Inhibitor Withdrawal after Six Months Associates with Improved Renal Function and Reduced Chronic Histopathology.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0139247
- By:
- Publication type:
- Article
Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease.
- Published in:
- 2015
- By:
- Publication type:
- Case Study